MTAC
TriSalus Life Sciences Inc
$11.34
Earnings Summary
Net Profits | $-1Mn |
Highlights
Net Profits:
TriSalus Life Sciences Inc’s net profit fell -141.7% since last year same period to $-1Mn in the Q2 2023. On a quarterly growth basis, TriSalus Life Sciences Inc has generated -122.06% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the TriSalus Life Sciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0 |
EPS Estimate Current Year | 0 |
Highlights
EPS Estimate Current Quarter:
TriSalus Life Sciences Inc’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.
EPS Estimate Current Year:
TriSalus Life Sciences Inc’s earning per share (EPS) estimates for the current year stand at 0.
Key Ratios
Key ratios of the TriSalus Life Sciences Inc post its Q2 2023 earnings
Earning Per Share (EPS) | -0.12 |
Highlights
Earning Per Share (EPS):
TriSalus Life Sciences Inc’s earning per share (EPS) fell -254.13% since last year same period to -0.12 in the Q2 2023. This indicates that the TriSalus Life Sciences Inc has generated -254.13% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2020-09-30 | 0 | -0 | -Inf% |
₹0 US Stocks a/c Opening Fee